Showing all 4 results
Neostigmine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic bromide salt.
Active Ingredient Strength Primary Clinical Function Neostigmine Bromide Ph.Eur./USP 15 mg Global Clinical Standard: Base therapeutic oral unit for the continuous, meticulously spaced symptomatic management of Myasthenia Gravis. Excipients Lactose Monohydrate / Maize Starch / Povidone K30 / Talc / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered specifically for rapid, predictable gastric dissolution to ensure precise symptom control within 30 to 45 minutes of ingestion) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic neurology dispensing, as patients may require up to 10-15 tablets per day in divided doses).
Thiocolchicoside Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Hard Gelatin Capsule, packed in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute stability of the semi-synthetic active ingredient.
Active Ingredient Strength Primary Clinical Use Thiocolchicoside INN/Ph.Eur. 4 mg Initiation / Mild Spasm: Standard adult dose for moderate acute back pain and torticollis (wry neck). Thiocolchicoside INN/Ph.Eur. 8 mg Severe Trauma: Maximum single-dose therapy for severe, immobilizing orthopedic spasms. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Magnesium Stearate Diluent / Lubricant (Engineered for immediate gastric dissolution and rapid onset of relief) Tizanidine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, optimized with a deep score-line to allow for exact 1 mg micro-dosing if required by pediatric or highly sensitive geriatric patients.
Active Ingredient Strength Primary Clinical Use Tizanidine Hydrochloride USP/Ph.Eur. 2 mg (Equivalent to Tizanidine base) MANDATORY INITIATION: Dose titration and mild-to-moderate spasm relief. Excipients Anhydrous Lactose / Microcrystalline Cellulose / Colloidal Silicon Dioxide / Stearic Acid Diluent / Glidant / Lubricant (Engineered for immediate gastric dispersion and precise splitting) Tolperisone Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips, optimized for both acute 7-day dispensing and chronic rehabilitative regimens.
Active Ingredient Strength Primary Clinical Use Tolperisone Hydrochloride INN/Ph.Eur. 150 mg Global Standard: Target adult dose for acute spasms and post-stroke spasticity. Excipients Microcrystalline Cellulose / Citric Acid Monohydrate / Stearic Acid / Hypromellose Diluent / Stabilizer / Film Coating (Engineered for immediate gastric dispersion)
